Raymond James & Associates’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-25,531
| Closed | -$849K | – | 3593 |
|
|
2020
Q2 | $849K | Buy |
25,531
+8,602
| +51% | +$286K | ﹤0.01% | 2260 |
|
|
2020
Q1 | $460K | Buy |
+16,929
| New | +$460K | ﹤0.01% | 2469 |
|
|
2019
Q4 | – | Sell |
-12,240
| Closed | -$159K | – | 3646 |
|
|
2019
Q3 | $159K | Hold |
12,240
| – | – | ﹤0.01% | 3300 |
|
|
2019
Q2 | $152K | Sell |
12,240
-1,000
| -8% | -$12.4K | ﹤0.01% | 3307 |
|
|
2019
Q1 | $192K | Sell |
13,240
-2,620
| -17% | -$38K | ﹤0.01% | 3228 |
|
|
2018
Q4 | $175K | Sell |
15,860
-3,656
| -19% | -$40.3K | ﹤0.01% | 3168 |
|
|
2018
Q3 | $513K | Buy |
19,516
+2,599
| +15% | +$68.3K | ﹤0.01% | 2681 |
|
|
2018
Q2 | $346K | Buy |
16,917
+8
| +0% | +$164 | ﹤0.01% | 2917 |
|
|
2018
Q1 | $307K | Buy |
16,909
+823
| +5% | +$14.9K | ﹤0.01% | 2853 |
|
|
2017
Q4 | $224K | Buy |
16,086
+115
| +0.7% | +$1.6K | ﹤0.01% | 2973 |
|
|
2017
Q3 | $295K | Sell |
15,971
-604
| -4% | -$11.2K | ﹤0.01% | 2792 |
|
|
2017
Q2 | $280K | Sell |
16,575
-145
| -0.9% | -$2.45K | ﹤0.01% | 2745 |
|
|
2017
Q1 | $223K | Buy |
16,720
+694
| +4% | +$9.26K | ﹤0.01% | 2849 |
|
|
2016
Q4 | $241K | Sell |
16,026
-43
| -0.3% | -$647 | ﹤0.01% | 2763 |
|
|
2016
Q3 | $188K | Buy |
+16,069
| New | +$188K | ﹤0.01% | 2845 |
|